Needham analyst Matt McGinley raised the firm’s price target on Green Thumb Industries to $17 from $15.50 and keeps a Buy rating on the shares. The company had a strong Q1 with better-than-expected 11% top-line growth which, combined with greater scale and efficiency gains, generated its best quarterly gross and EBITDA margins since 2021, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GTBIF:
- Green Thumb Industries Unveils Q1 2024 Financial Results
- Green Thumb Industries Reports First Quarter 2024 Results
- Here’s What You Missed in Cannabis, Psychedelics This Week
- Craig-Hallum recommends buying Green Thumb, TerrAscend after DEA news
- DEA said to propose ‘most notable cannabis reform in decades,’ says AGP
